Course: Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination
CME Credits: 1.00
Released: 2021-07-22
Vaccine-induced adenopathy after COVID-19 vaccination in breast imaging has received significant media attention, with evolving literary correspondence on management. Patients’ self-report of axillary swelling following COVID-19 vaccination was reported as high as 16%. The National Comprehensive Cancer Network and Society of Breast Imaging recommended to consider scheduling screening breast imaging 4 to 6 weeks after the second COVID-19 vaccination dose when possible. However, the actual incidence, timing, and characteristics of mammographic axillary adenopathy following COVID-19 vaccination remain uncertain.
Educational Objective
To identify the key insights or developments described in this article
View Full Course